Regulated-industry sales is context-heavy.
The relevant facts are rarely in one place. Account evidence, regulatory changes, clinical activity, compliance claims, stakeholder history, and commercial timing all shape the next conversation.
Why DOSSIRI
Built for regulated industry. Not adapted for it.
DOSSIRI exists because life sciences and regulated-industry sales require more than a generic CRM, a spreadsheet, or a one-off AI prompt.
Generic CRMs record activity. They do not prepare you.
Most CRMs are built for management visibility: pipeline, forecasting, activity logging, and reporting. Those are important, but they do not solve the seller's preparation problem.
AI alone is not enough.
A general-purpose model can summarize what you paste into it. DOSSIRI is designed to accumulate account intelligence over time, preserve account memory, and ground preparation in evidence.
The Problem
The work that determines whether a deal moves forward happens before the call.
Preparation in regulated markets means understanding the account, the people, the timing, the regulatory context, the buying motion, and what evidence supports each assumption.
DOSSIRI gives that work a place to live. Each account becomes a workspace where CRM records and intelligence accumulate into usable account memory.
Evidence Before Action
What do we know?
Where did it come from?
How strong is the evidence?
What is still uncertain?
What should the seller decide?
Product Principles
DOSSIRI is designed around how regulated-industry sellers actually work.
CRM First
Intelligence Native
Evidence Before Action
Human Judgment Wins
Timeline as Account Memory
Compliance Aware
Prepare with evidence. Decide with judgment.
DOSSIRI does not replace the seller. It gives the seller better context before the moment that matters.
Request Early Access →